Ferroptosis inhibitors attenuate sepsis associated acute kidney injury by protecting ferroportin

ZHANG Kai-qi,WU Jing-kui,JIANG Na,LIN Qi-sheng,ZHU Xu-ying,LI Jia-lin,SHAO Xing-hua,YANG Yuan-ting,NI Zhao-hui

DOI: https://doi.org/10.12025/j.issn.1008-6358.2023.20230266

2023-01-01

Abstract:Objective To explore the role of ferroptosis in LPS-induced sepsis associated acute kidney injury(S-AKI via in vivo and in vitro models. Methods A mouse model of sepsis was established and randomly divided into 4 groups: the control group, lipopolysaccharide（LPS） group, LPS+Ferrostatin-1（Fer-1） group and LPS+Deferoxamine（DFO） group, 3 mice for each group. Mice in LPS group were administered intraperitoneally with LPS at a dose of 15 mg/kg, and those in ferroptosis inhibitor group were intraperitoneally injected with Fer-1（5 mg/kg） or DFO（100 mg/kg） 30 minutes before LPS injection, respectively. Blood and kidney samples were collected 24 hours later for renal function and ferroptosis markers detection. Human renal tubular epithelial cells（HK-2） were exposed to 100 μg/mL LPS stimulation for 24 h, and cell viability, labile iron pool（LIP） and lipid peroxidation were detected. After transfection to HK-2 cells with siRNA against ferroportin（FPN）, the expression of ferroptosis markers were detected. Results Compared with the control group, the levels of serum creatinine and urea nitrogen of mice in LPS group were significantly higher, the renal pathological injury was aggravated, and ferroptosis markers were remarkably increased. However,ferroptosis inhibitors could significantly relieve the kidney functional and pathological injury induced by LPS, and reduce the expression of ferroptosis markers. Meanwhile, FPN expression was significantly down-regulated in LPS-induced S-AKI group both in vivo and in vitro, and obvious ferroptosis markers were observed in HK-2 cells silenced by siRNA for FPN, suggesting that FPN was involved in ferroptotic injury. qRT-PCR results showed that down-regulation of FPN was associated with increased hepcidin in the kidney. Further tests showed that LPS activated the hepcidin promoter IL-6/STAT3 pathway, while Fer-1 and DFO inhibited the activation of related pathway, reduced hepcidin mRNA expression, and prevented the down-regulation of FPN. Conclusions LPS can induce down-regulation of FPN mediated ferroptosis, and ferroptosis inhibitors may play a protective role in LPS-induced S-AKI through inhibiting the degradation of FPN by hepcidin.